

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in understanding and managing... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-661/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-661" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in understanding and managing infectious diseases in solid organ transplant recipients" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in understanding and managing infectious diseases in solid organ transplant recipients.">
            <meta name="og:description" content="Read the latest article version by Claire Aguilar, Shahid Husain, Olivier Lortholary, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="15523">
            <meta name="article-id" content="14262">
            <meta name="dc.title" content="Recent advances in understanding and managing infectious diseases in solid organ transplant recipients">
            <meta name="dc.description" content=" Background: Undergoing solid organ transplantation (SOT) exposes the recipient to various infectious risks, including possible transmission of pathogen by the transplanted organ, post-surgical infections, reactivation of latent pathogens, or novel infections. 
 Recent advances: In the last few years, the emergence of Zika virus has raised concerns in the transplant community. Few cases have been described in SOT patients, and these were associated mainly with moderate disease and favorable outcome; the notable exception is a recent case of fatal meningo-encephalopathy in a heart transplant recipient. Because of the advances in treating hepatitis C, several teams recently started to use organs from hepatitis C-positive donors. The worldwide increasing incidence of multidrug-resistant pathogens, as well as the increasing incidence of Clostridioides  difficile infection, is of particular concern in SOT patients. In the field of mycology, the main recent therapeutic advance is the availability of isavuconazole for the treatment of invasive aspergillosis and mucormycosis. This drug has the advantage of minimal interaction with calcineurin inhibitors. Regarding the viral reactivations occurring after transplant, cytomegalovirus (CMV) infection is still a significant issue in SOT patients. The management of resistant CMV remains particularly difficult. The approval of letermovir, albeit in bone marrow transplantation, and the therapeutic trial of maribavir bring a ray of hope. Another advancement in management of post-transplant infections is the development of in vitro tests evaluating pathogen-specific immune response, such as immunodiagnostics for CMV and, more recently, tests for monitoring immunity against BK virus. 
 Conclusion: The increasing number of organ transplantations, the use of newer immunosuppressive drugs, and high-risk donors continue to define the landscape of transplant infectious diseases in the current era.">
            <meta name="dc.subject" content="donor-derived infections, Hyperammonemia syndrome, immune monitoring, vaccine">
            <meta name="dc.creator" content="Aguilar, Claire">
            <meta name="dc.creator" content="Husain, Shahid">
            <meta name="dc.creator" content="Lortholary, Olivier">
            <meta name="dc.date" content="2018/05/24">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.14262.1">
            <meta name="dc.source" content="F1000Research 2018 7:661">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="donor-derived infections">
            <meta name="prism.keyword" content="Hyperammonemia syndrome">
            <meta name="prism.keyword" content="immune monitoring">
            <meta name="prism.keyword" content="vaccine">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/05/24">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="661">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.14262.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-661">
            <meta name="citation_title" content="Recent advances in understanding and managing infectious diseases in solid organ transplant recipients">
            <meta name="citation_abstract" content=" Background: Undergoing solid organ transplantation (SOT) exposes the recipient to various infectious risks, including possible transmission of pathogen by the transplanted organ, post-surgical infections, reactivation of latent pathogens, or novel infections. 
 Recent advances: In the last few years, the emergence of Zika virus has raised concerns in the transplant community. Few cases have been described in SOT patients, and these were associated mainly with moderate disease and favorable outcome; the notable exception is a recent case of fatal meningo-encephalopathy in a heart transplant recipient. Because of the advances in treating hepatitis C, several teams recently started to use organs from hepatitis C-positive donors. The worldwide increasing incidence of multidrug-resistant pathogens, as well as the increasing incidence of Clostridioides  difficile infection, is of particular concern in SOT patients. In the field of mycology, the main recent therapeutic advance is the availability of isavuconazole for the treatment of invasive aspergillosis and mucormycosis. This drug has the advantage of minimal interaction with calcineurin inhibitors. Regarding the viral reactivations occurring after transplant, cytomegalovirus (CMV) infection is still a significant issue in SOT patients. The management of resistant CMV remains particularly difficult. The approval of letermovir, albeit in bone marrow transplantation, and the therapeutic trial of maribavir bring a ray of hope. Another advancement in management of post-transplant infections is the development of in vitro tests evaluating pathogen-specific immune response, such as immunodiagnostics for CMV and, more recently, tests for monitoring immunity against BK virus. 
 Conclusion: The increasing number of organ transplantations, the use of newer immunosuppressive drugs, and high-risk donors continue to define the landscape of transplant infectious diseases in the current era.">
            <meta name="citation_description" content=" Background: Undergoing solid organ transplantation (SOT) exposes the recipient to various infectious risks, including possible transmission of pathogen by the transplanted organ, post-surgical infections, reactivation of latent pathogens, or novel infections. 
 Recent advances: In the last few years, the emergence of Zika virus has raised concerns in the transplant community. Few cases have been described in SOT patients, and these were associated mainly with moderate disease and favorable outcome; the notable exception is a recent case of fatal meningo-encephalopathy in a heart transplant recipient. Because of the advances in treating hepatitis C, several teams recently started to use organs from hepatitis C-positive donors. The worldwide increasing incidence of multidrug-resistant pathogens, as well as the increasing incidence of Clostridioides  difficile infection, is of particular concern in SOT patients. In the field of mycology, the main recent therapeutic advance is the availability of isavuconazole for the treatment of invasive aspergillosis and mucormycosis. This drug has the advantage of minimal interaction with calcineurin inhibitors. Regarding the viral reactivations occurring after transplant, cytomegalovirus (CMV) infection is still a significant issue in SOT patients. The management of resistant CMV remains particularly difficult. The approval of letermovir, albeit in bone marrow transplantation, and the therapeutic trial of maribavir bring a ray of hope. Another advancement in management of post-transplant infections is the development of in vitro tests evaluating pathogen-specific immune response, such as immunodiagnostics for CMV and, more recently, tests for monitoring immunity against BK virus. 
 Conclusion: The increasing number of organ transplantations, the use of newer immunosuppressive drugs, and high-risk donors continue to define the landscape of transplant infectious diseases in the current era.">
            <meta name="citation_keywords" content="donor-derived infections, Hyperammonemia syndrome, immune monitoring, vaccine">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Claire Aguilar">
            <meta name="citation_author_institution" content="Division of Infectious Diseases, Multi-Organ Transplant Program, Department of Medicine, University of Toronto, University Health Network, Toronto, ON, Canada">
            <meta name="citation_author" content="Shahid Husain">
            <meta name="citation_author_institution" content="Division of Infectious Diseases, Multi-Organ Transplant Program, Department of Medicine, University of Toronto, University Health Network, Toronto, ON, Canada">
            <meta name="citation_author" content="Olivier Lortholary">
            <meta name="citation_author_institution" content="Necker Pasteur Center for Infectious Diseases and Tropical Medicine, Paris Descartes University, IHU Imagine, Paris, France">
            <meta name="citation_publication_date" content="2018/05/24">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="661">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.14262.1">
            <meta name="citation_firstpage" content="661">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-661/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-661.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=15523 /> <input type=hidden id=articleId name=articleId value=14262 /> <input type=hidden id=xmlUrl value="/articles/7-661/v1/xml"/> <input type=hidden id=xmlFileName value="-7-661-v1.xml"> <input type=hidden id=article_uuid value=3b91532e-ee39-48cf-87a9-ac76bfc85ab6 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in understanding and managing infectious diseases in solid organ transplant recipients"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.14262.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.14262.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-661"
  },
  "headline": "Recent advances in understanding and managing infectious diseases in solid organ transplant recipients",
  "datePublished": "2018-05-24T16:20:09",
  "dateModified": "2018-05-24T16:20:09",
  "author": [
    {
      "@type": "Person",
      "name": "Claire Aguilar"
    },    {
      "@type": "Person",
      "name": "Shahid Husain"
    },    {
      "@type": "Person",
      "name": "Olivier Lortholary"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Background: Undergoing solid organ transplantation (SOT) exposes the recipient to various infectious risks, including possible transmission of pathogen by the transplanted organ, post-surgical infections, reactivation of latent pathogens, or novel infections.
Recent advances: In the last few years, the emergence of Zika virus has raised concerns in the transplant community. Few cases have been described in SOT patients, and these were associated mainly with moderate disease and favorable outcome; the notable exception is a recent case of fatal meningo-encephalopathy in a heart transplant recipient. Because of the advances in treating hepatitis C, several teams recently started to use organs from hepatitis C-positive donors. The worldwide increasing incidence of multidrug-resistant pathogens, as well as the increasing incidence of Clostridioides difficile infection, is of particular concern in SOT patients. In the field of mycology, the main recent therapeutic advance is the availability of isavuconazole for the treatment of invasive aspergillosis and mucormycosis. This drug has the advantage of minimal interaction with calcineurin inhibitors. Regarding the viral reactivations occurring after transplant, cytomegalovirus (CMV) infection is still a significant issue in SOT patients. The management of resistant CMV remains particularly difficult. The approval of letermovir, albeit in bone marrow transplantation, and the therapeutic trial of maribavir bring a ray of hope. Another advancement in management of post-transplant infections is the development of in vitro tests evaluating pathogen-specific immune response, such as immunodiagnostics for CMV and, more recently, tests for monitoring immunity against BK virus.
Conclusion: The increasing number of organ transplantations, the use of newer immunosuppressive drugs, and high-risk donors continue to define the landscape of transplant infectious diseases in the current era."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-661/v1",
            "name": "Recent advances in understanding and managing infectious diseases..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in understanding and managing infectious diseases... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=15523 data-id=14262 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14262.1" data-recommended="" data-doi="10.12688/f1000research.14262.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-661/v1/pdf?article_uuid=3b91532e-ee39-48cf-87a9-ac76bfc85ab6" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-14262-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-14262-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-14262-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Aguilar C, Husain S and Lortholary O. Recent advances in understanding and managing infectious diseases in solid organ transplant recipients [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):661 (<a class=new-orange href="https://doi.org/10.12688/f1000research.14262.1" target=_blank>https://doi.org/10.12688/f1000research.14262.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-14262-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=14262 id=track-article-signin-14262 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14262?target=/articles/7-661/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=15523 /> <input name=articleId type=hidden value=14262 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in understanding and managing infectious diseases in solid organ transplant recipients</h1><span class=other-info> [version 1; peer review: 3 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Claire Aguilar<a href="https://orcid.org/0000-0001-9181-2239" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-9181-2239</div><sup>1</sup>,&nbsp;</span><span class="">Shahid Husain<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:olivier.lortholary@aphp.fr" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Olivier Lortholary</span></a><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Claire Aguilar<a href="http://orcid.org/0000-0001-9181-2239" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-9181-2239</div><sup>1</sup>,&nbsp;</span><span class="">Shahid Husain<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:olivier.lortholary@aphp.fr" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Olivier Lortholary</span></a><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 24 May 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.14262.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Division of Infectious Diseases, Multi-Organ Transplant Program, Department of Medicine, University of Toronto, University Health Network, Toronto, ON, Canada<br/> <sup>2</sup> Necker Pasteur Center for Infectious Diseases and Tropical Medicine, Paris Descartes University, IHU Imagine, Paris, France<br/> <p> <div class=margin-bottom> Claire Aguilar <br/> <span>Roles: </span> Writing – Original Draft Preparation </div> <div class=margin-bottom> Shahid Husain <br/> <span>Roles: </span> Writing – Review & Editing </div> <div class=margin-bottom> Olivier Lortholary <br/> <span>Roles: </span> Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=8468-34156></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=34627-34154></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=34628-34155></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> <b>Background:</b> Undergoing solid organ transplantation (SOT) exposes the recipient to various infectious risks, including possible transmission of pathogen by the transplanted organ, post-surgical infections, reactivation of latent pathogens, or novel infections.<br/> <b>Recent advances:</b> In the last few years, the emergence of Zika virus has raised concerns in the transplant community. Few cases have been described in SOT patients, and these were associated mainly with moderate disease and favorable outcome; the notable exception is a recent case of fatal meningo-encephalopathy in a heart transplant recipient. Because of the advances in treating hepatitis C, several teams recently started to use organs from hepatitis C-positive donors. The worldwide increasing incidence of multidrug-resistant pathogens, as well as the increasing incidence of <i>Clostridioides</i><i> difficile</i> infection, is of particular concern in SOT patients. In the field of mycology, the main recent therapeutic advance is the availability of isavuconazole for the treatment of invasive aspergillosis and mucormycosis. This drug has the advantage of minimal interaction with calcineurin inhibitors. Regarding the viral reactivations occurring after transplant, cytomegalovirus (CMV) infection is still a significant issue in SOT patients. The management of resistant CMV remains particularly difficult. The approval of letermovir, albeit in bone marrow transplantation, and the therapeutic trial of maribavir bring a ray of hope. Another advancement in management of post-transplant infections is the development of <i>in vitro</i> tests evaluating pathogen-specific immune response, such as immunodiagnostics for CMV and, more recently, tests for monitoring immunity against BK virus.<br/> <b>Conclusion: </b>The increasing number of organ transplantations, the use of newer immunosuppressive drugs, and high-risk donors continue to define the landscape of transplant infectious diseases in the current era. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> donor-derived infections, Hyperammonemia syndrome, immune monitoring, vaccine </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Olivier Lortholary (<a href="mailto:olivier.lortholary@aphp.fr">olivier.lortholary@aphp.fr</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Olivier Lortholary </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2018 Aguilar C <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Aguilar C, Husain S and Lortholary O. Recent advances in understanding and managing infectious diseases in solid organ transplant recipients [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):661 (<a href="https://doi.org/10.12688/f1000research.14262.1" target=_blank>https://doi.org/10.12688/f1000research.14262.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 24 May 2018, <b>7</b>(F1000 Faculty Rev):661 (<a href="https://doi.org/10.12688/f1000research.14262.1" target=_blank>https://doi.org/10.12688/f1000research.14262.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 24 May 2018, <b>7</b>(F1000 Faculty Rev):661 (<a href="https://doi.org/10.12688/f1000research.14262.1" target=_blank>https://doi.org/10.12688/f1000research.14262.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d4572e191>Introduction</h2><p class="" id=d4572e194>Solid organ transplantation (SOT) is a life-saving procedure. The advances in surgical techniques, as well as the application of better preventive and management strategies for organ rejection, have led to improved outcomes<sup><a href="#ref-1">1</a>–<a href="#ref-3">3</a></sup>. Conversely, the use of immunosuppressive medications may result in high infection risk and significant morbidity and mortality. Ongoing assessment of the epidemiology of those infections and evaluation of the modalities of prevention and treatment are critical to further improve outcomes in SOT recipients.</p><p class="" id=d4572e204>In this review, we will focus on recent advances in the understanding and management of infections in SOT patients, which can occur at different phases of the transplant process. We will initially describe the emergence of some newer donor-derived infections, followed by the summary of new drugs available for treating infections in SOT patients, prior to discussing the role of immune monitoring in the management of infections, and finally we will highlight the potential role for the newer vaccines.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4572e210>Donor-derived infections</h2><div class=section><a name=d4572e213 class=n-a></a><h3 class=section-title>The fear of Zika virus…</h3><p class="" id=d4572e218>Since 2015, the Zika virus emerged initially in South America and then in the Caribbean, Central America, and the southern US, raising concerns in the transplant community about the risk of transmission through organ donation and possible risks of severe disease in SOT recipients<sup><a href="#ref-4">4</a>,<a href="#ref-5">5</a></sup>. Zika virus belongs to the flavivirus family. In immunocompetent individuals, Zika virus can induce viral illness with symptoms similar to those of other arbovirus infections but is in fact asymptomatic in the majority of cases. It has also been associated with neurological manifestations such as Guillain-Barré syndrome and meningo-encephalitis. Besides transmission by mosquito bite, known routes of transmission are sexual, blood-derived, or materno-fetal. It has also been shown that in immunocompetent patients, Zika virus can persist in semen and saliva for several weeks after clearance of viremia. As such, potential persistence of Zika virus in organs needs further investigation. Zika can also be acquired after transplantation if the recipient lives in or travels to an endemic area. In 2016, Nogueira <i>et al</i>. published a case series of four SOT recipients (two kidney and two liver transplant recipients) in Brazil who presented with viral symptoms and tested positive for Zika virus<sup><a href="#ref-6">6</a></sup>. The time from transplant to positive testing was 43 to 590 days, and the testing of donors was not available. All patients experienced complications such as graft dysfunction or bacterial infections, although it is hard to know what role the Zika infection had in the symptoms. None of the patients had neurological symptoms, and all survived<sup><a href="#ref-6">6</a></sup>. However, in 2017, Schwartzmann <i>et al</i>. reported a case of fatal meningo-encephalitis due to Zika virus in a heart transplant recipient<sup><a href="#ref-7">7</a></sup>. Zika virus should be considered a possible cause of meningo-encephalitis in patients living in endemic areas as well as in patients who travelled to those areas. In immunocompetent patients, cases with few weeks between the onset of infection and neurological symptoms have been reported, warranting caution in SOT patient populations in which little is known about Zika virus infection<sup><a href="#ref-8">8</a></sup>. Recent transplant guidelines suggest performing nucleic acid testing for donors who have recently travelled in endemic areas and to exclude the organ if the donor is viremic<sup><a href="#ref-9">9</a></sup>. However, the low number of reported cases so far and the relative paucity of data on post-transplant infection question the validity of those recommendations. More studies are required to define the best strategies for donor screening, diagnosis, and management of Zika virus infections in SOT recipients.</p></div><div class=section><a name=d4572e256 class=n-a></a><h3 class=section-title>… the surprising <i>Ureaplasma spp</i>.</h3><p class="" id=d4572e264>In the last few years, an unexpected infection, probably donor-derived, has been reported in lung transplant recipients. In this population, a rare but severe disease named hyperammonemia syndrome has been described since the ’90s<sup><a href="#ref-10">10</a></sup>. Hyperammonemia syndrome is characterized by elevated ammonia plasma levels in the early transplant period, complicated by neurologic symptoms, which can be fatal<sup><a href="#ref-11">11</a></sup>. In 2015, Bharat <i>et al</i>. reported several cases of hyperammonemia syndrome associated with the detection of <i>Ureaplasma urealyticum</i>, <i>Ureaplasma parvum</i>, or <i>Mycoplasma hominis</i> in respiratory samples and blood from lung transplant recipients<sup><a href="#ref-12">12</a></sup>. In 2017, Fernandez <i>et al</i>. reported another case with detection of <i>U. urealyticum</i> in both recipient and donor respiratory samples, suggesting a donor-derived infection<sup><a href="#ref-13">13</a></sup><i>.</i> The same team conducted a prospective study to assess the incidence of <i>Ureaplasma spp.</i> in a cohort of donors. They found that 4% of donors’ respiratory samples were positive for <i>Ureaplasma spp.</i><sup><a href="#ref-14">14</a></sup>. Most of the positive samples were from young males, who had an aspiration event prior to death. Some centers routinely monitor ammonia levels in all lung transplant recipients during the first weeks post-transplantation and institute hemodialysis in cases of hyperammonemia along with antibiotic treatment directed against <i>Ureaplasma</i> and <i>Chlamydia</i>. Another strategy is to perform polymerase chain reaction for <i>Ureaplasma spp.</i> and <i>Mycoplasma spp.</i> in respiratory samples from donors and initiate therapy in the recipients if the donor sample is positive. However, these strategies need to be evaluated.</p></div><div class=section><a name=d4572e328 class=n-a></a><h3 class=section-title>… and a worrisome Candida infection</h3><p class="" id=d4572e333>In 2017, the first case of donor-derived infection with <i>Candida auris</i> in a lung transplant recipient was reported in the US<sup><a href="#ref-15">15</a></sup>. <i>C. auris</i> is an emerging Candida species first described in 2009 in Japan and then in a dozen other countries<sup><a href="#ref-16">16</a></sup>. Whole-genome sequencing techniques identified four different clades with distinct geographical clustering, suggesting independent emergence in different areas. Isolates frequently exhibit high minimal inhibitory concentrations to antifungal drugs, and <i>C. auris</i> infections have been associated with poor outcomes<sup><a href="#ref-17">17</a></sup>. Moreover, the microbiological identification can be difficult. In the case reported by Azar <i>et al</i>.<sup><a href="#ref-15">15</a></sup>, the yeast was initially identified as <i>C. haemulonii</i>, which has been reported in several other cases of <i>C. auris</i> infection. The emergence of this multiply resistant Candida species warrants caution with regard to the identification of yeast in donor samples.</p></div><div class=section><a name=d4572e372 class=n-a></a><h3 class=section-title>A paradigm shift in donor-derived infections</h3><p class="" id=d4572e377>A pressing issue in transplantation is the gap between the number of patients awaiting a transplantation and the number of organs available. In order to increase the pool of donors, retrieving organs from previously excluded donors is an emerging strategy. Several centers reported transplantation from HIV-positive donors to HIV-positive recipients<sup><a href="#ref-18">18</a></sup> with favorable outcomes<sup><a href="#ref-19">19</a>,<a href="#ref-20">20</a></sup>. Moreover, the recent advances in antiviral therapies against hepatitis C have led to new perspectives in the field of transplantation, as those drugs have excellent efficacy and tolerance profiles, including in SOT recipients<sup><a href="#ref-21">21</a></sup>. In the last year, several centers have reported the use of organs from hepatitis C donors with detectable viremia at the time of transplant<sup><a href="#ref-22">22</a></sup>, and so far outcomes have been favorable with either monitoring of viral load triggering treatment<sup><a href="#ref-23">23</a>,<a href="#ref-24">24</a></sup> or pre-emptive treatment<sup><a href="#ref-25">25</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4572e415>Infections acquired after transplantation: new treatments available</h2><div class=section><a name=d4572e418 class=n-a></a><h3 class=section-title>Multidrug-resistant bacteria in solid organ transplantation</h3><p class="" id=d4572e423>The global increase in antimicrobial resistance, which is a worldwide concern<sup><a href="#ref-26">26</a></sup>, is also particularly worrisome in the context of organ transplantation<sup><a href="#ref-27">27</a></sup>. SOT patients are highly exposed to the healthcare system, undergo different types of invasive procedures, and often require several courses of antibiotics. Few new antibiotics have been marketed in the last few years. Ceftolozane is a new beta-lactamin with anti-<i>Pseudomonas</i> activity, and the combination of ceftolozane-tazobactam has a broad spectrum, including <i>Enterobacteriacae</i> producing extended-spectrum beta-lactamase (ESBL). Ceftolozane-tazobactam, indicated mainly for multidrug-resistant <i>Pseudomonas</i> infections, has been approved by the US Food and Drug Administration (FDA) for the treatment of complicated intra-abdominal and urinary tract infections<sup><a href="#ref-28">28</a>,<a href="#ref-29">29</a></sup>. A recent retrospective study of 21 patients who received treatment for severe infections (pneumonia in 86% of cases) due to multidrug-resistant <i>Pseudomonas spp.</i> included eight SOT patients. Ceftolozane-tazobactam was well tolerated and was effective in 71% of patients. However, resistance to ceftolozane-tazobactam developed during treatment in three patients<sup><a href="#ref-30">30</a></sup>. Another interesting antibacterial agent is the association of ceftazidime with a new beta-lactamase inhibitor, avibactam, which inhibits the activity of some carbapenemases<sup><a href="#ref-31">31</a></sup>. In this context of increasing resistance, antimicrobial stewardship programs have developed tremendously in the last decade. Although the general practice is to provide treatment to SOT patients empirically with broad-spectrum antibiotics and to use prolonged duration of therapies, antimicrobial stewardship probably has a role to play in SOT recipients as well. So <i>et al</i>. conducted a retrospective analysis of antimicrobial prescriptions in an SOT population<sup><a href="#ref-32">32</a></sup>. A total of 176 audits were performed in 139 patients, and 30% of antimicrobial prescriptions were stewardship discordant<sup><a href="#ref-32">32</a></sup>. Several centers have now implemented dedicated stewardship programs<sup><a href="#ref-33">33</a></sup>.</p></div><div class=section><a name=d4572e479 class=n-a></a><h3 class=section-title><i>Clostridioides difficile</i>&nbsp;</h3><p class="" id=d4572e486>The other consequence of broad-spectrum antibiotic use is the increase of <i>Clostridioides difficile</i> infections<sup><a href="#ref-34">34</a></sup>. A meta-analysis of published data in SOT recipients from 1994 to 2014 estimated the overall prevalence at 7.4%, and the recurrence rate was 19.7%<sup><a href="#ref-35">35</a></sup>. Interestingly, a recent case control study in Switzerland found an increased risk of graft loss in SOT patients with <i>C. difficile</i> infection<sup><a href="#ref-36">36</a></sup>. With regard to treatment, besides the use of antibiotics active against <i>C. difficile</i> (vancomycin, metronidazole, and fidaxomicin), other approaches are in development. Fecal transplantation has been used more and more in the last decade, and its efficacy has been established in immunocompetent patients to reduce the rate of recurrence of <i>C. difficile</i> colitis<sup><a href="#ref-37">37</a></sup>. However, the use in immunocompromised patients has been limited because of concerns about side effects and the sparse data in SOT patients<sup><a href="#ref-38">38</a>,<a href="#ref-39">39</a></sup>. Alraba <i>et al</i>. recently reported outcomes of 13 patients receiving fecal transplantation for recurrent <i>C. difficile</i> infection, including six SOT recipients. Although the fecal transplant was successful in six immunocompetent patients, three SOT patients failed<sup><a href="#ref-40">40</a></sup>. More recently, two monoclonal antibodies directed against <i>C. difficile</i> toxin A and toxin B—actoxumab and bezlotoxumab, respectively—have been evaluated in a double-blind, randomized placebo-controlled trial<sup><a href="#ref-41">41</a></sup>, including a cohort of 21.4% of immunocompromised hosts. In this study, use of bezlotoxumab was associated with a lower recurrence rate compared with placebo. The potential benefit of bezlotoxumab in SOT patients needs to be determined.</p></div><div class=section><a name=d4572e544 class=n-a></a><h3 class=section-title>Fungal infections</h3><p class="" id=d4572e549>In the field of fungal infections, the major news in the last few years has been the approval of isavuconazole, a new triazole agent with broad activity, including <i>Aspergillus spp.</i> and mucorales. Its non-inferiority to voriconazole for the treatment of invasive aspergillosis has been established in a randomized clinical trial in patients with hematological malignancies<sup><a href="#ref-42">42</a></sup>. Its efficacy in cases of mucormycosis was suggested in a single-arm control trial involving a limited number of patients combined with a case control study<sup><a href="#ref-43">43</a></sup><i>.</i> Although isavuconazole was approved as first-line treatment of mucormycosis, liposomal amphotericin B remains a reference treatment in this indication. Interestingly, a prospective pilot study assessing the use of a high dose of liposomal amphotericin B, combined with surgery when feasible, showed a superior response rate at 12 weeks of treatment compared with the rates reported with isavuconazole. However, this study included only three SOT patients<sup><a href="#ref-44">44</a></sup>. The role of isavuconazole in prophylaxis and treatment of fungal infections in SOT patients needs to be determined. One advantage is the profile of tolerability of isavuconazole, which has less liver toxicity than voriconazole, and lack of nephrotoxicity, which can be an issue with liposomal amphotericin B. Like other triazoles, isavuconazole is an inhibitor of cytochrome P450 but inhibits only one isoenzyme compared with the three inhibited by voriconazole. Data about drug interactions with calcineurin inhibitors were initially reported in healthy volunteers<sup><a href="#ref-45">45</a></sup> and showed a 1.3-fold increased exposure to cyclosporine, 2.3-fold increase to tacrolimus, and 1.8-fold increase to sirolimus. Rivosecchi <i>et al</i>. recently reported their experience in Pittsburgh, where a universal prophylaxis with isavuconazole has been established in all SOT patients after an outbreak of mucormycosis<sup><a href="#ref-46">46</a></sup>. The authors found that overall the changes of tacrolimus plasma concentrations induced by the co-administration of isavuconazole were mild, and a 1.3-fold decrease in tacrolimus dose was necessary to maintain the tacrolimus level. Interestingly, the changes in tacrolimus plasma concentrations were seen mostly in liver transplant recipients.</p></div><div class=section><a name=d4572e582 class=n-a></a><h3 class=section-title>Viral infections</h3><p class="" id=d4572e587>Cytomegalovirus (CMV) infection remains a significant issue in SOT patients. Additionally, the management of infection with viruses resistant to first-line treatment (ganciclovir and valganciclovir) is particularly challenging, as alternative drugs (foscarnet and cidofovir) carry significant toxicities. As such, new drugs possessing a better toxicity profile are eagerly awaited in SOT patients. Maribavir is an inhibitor of UL97 viral kinase. In a study of liver transplant recipients, the use of maribavir 100 mg twice daily did not prevent CMV infections<sup><a href="#ref-47">47</a>,<a href="#ref-48">48</a></sup>. However, its efficacy for the treatment of refractory or resistant CMV disease in SOT patients has been reported with higher doses<sup><a href="#ref-49">49</a>,<a href="#ref-50">50</a></sup>. Occurrence of resistance has been reported in treatment with maribavir<sup><a href="#ref-51">51</a></sup>. A phase 3 trial for the treatment of refractory or resistant infection in transplant patients is ongoing. Letermovir, a novel non-nucleoside CMV inhibitor targeting the viral terminase complex, was approved by the FDA in 2017 for the prevention of CMV infection in bone marrow transplantation. In this population, a phase 3 randomized trial is showing a superior efficacy of letermovir compared with placebo in preventing CMV disease<sup><a href="#ref-52">52</a></sup> with myelotoxicity and nephrotoxicity rates similar to those of placebo. Successful outcome was reported with compassionate use of letermovir in a lung transplant patient with CMV-resistant disease<sup><a href="#ref-53">53</a></sup>. Letermovir was also shown to be effective in treating CMV viremia in kidney transplant recipients<sup><a href="#ref-54">54</a></sup>, and a clinical trial comparing letermovir with valganciclovir for the prevention of CMV disease in donor-positive/recipient-negative kidney transplantation is starting (ClinicalTrials.gov identifier: NCT03443869). However, caution should be exercised in treating CMV infection with letermovir alone, as <i>in vitro</i> studies have shown rapid emergence of resistance on treatment<sup><a href="#ref-55">55</a></sup>. The lipid-conjugated analogue of cidofovir, brincidofovir, has high oral availability and less nephrotoxicity than cidofovir. Efficacy has been low in prevention in hematopoietic stem cell transplant patients, and few data are available in SOT recipients<sup><a href="#ref-56">56</a></sup>. Moreover, Faure <i>et al</i>. reported two cases of acute kidney injury in SOT patients who received brincidofovir<sup><a href="#ref-57">57</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4572e643>Reactivation of viral infections: role of immune monitoring</h2><p class="" id=d4572e646>SOT patients are prone to the reactivation of viruses which are usually latent in immunocompetent people, such as herpes viruses—herpes simplex virus (HSV), varicella zoster virus (VZV), CMV, Epstein-Barr virus (EBV), and human herpesvirus 8—or polyomavirus (BK virus and less frequently JC virus), whether those viruses are already latent in the recipient or latent in the organ transplanted. In this context, immunological tools have been developed with the objective of providing a personalized assessment of the risk of reactivation<sup><a href="#ref-58">58</a></sup>.</p><div class=section><a name=d4572e653 class=n-a></a><h3 class=section-title>Cytomegalovirus</h3><p class="" id=d4572e658><i>In vitro</i> tests have been developed to detect the release of interferon-gamma (IFN-γ) induced by stimulation of lymphocytes by CMV antigens. The most used test is QuantiFERON-CMV assay (Qiagen Ltd.), a commercially available enzyme-linked immunosorbent based assay<sup><a href="#ref-59">59</a></sup>. Several studies showed that positivity of QuantiFERON-CMV at the end of prophylactic valganciclovir correlates with lower incidence of CMV disease<sup><a href="#ref-60">60</a>,<a href="#ref-61">61</a></sup> and that patients with low viremia were more likely to have spontaneous clearance if they had positive QuantiFERON-CMV<sup><a href="#ref-62">62</a></sup>. However, data showing the use of this test in daily practice were missing. Recently, Kumar <i>et al</i>. reported the results of an interventional study using QuantiFERON-CMV in real-life practice<sup><a href="#ref-63">63</a></sup>. Patients were enrolled at completion of treatment for the first episode of CMV reactivation, and a QuantiFERON-CMV test was done with results available within 3 days. For patients with a positive test, no prophylaxis was given, whereas patients with negative QuantiFERON-CMV received 2 months of prophylaxis. Only one patient in the QuantiFERON-CMV-positive group had recurrence of asymptomatic CMV viremia. A large proportion with negative QuantiFERON-CMV developed recurrence while on secondary prophylaxis<sup><a href="#ref-63">63</a></sup><i>.</i> Further studies are warranted to define how QuantiFERON-CMV use could improve the management of CMV disease.</p></div><div class=section><a name=d4572e693 class=n-a></a><h3 class=section-title>Epstein-Barr virus</h3><p class="" id=d4572e698>EBV reactivation can be associated with post-transplant lymphoproliferative disorders (PTLDs) in SOT patients. Several studies reported the feasibility of detection of EBV immune response <i>in vitro</i> by various techniques such as tetramer detection, intracellular staining, or ElisPOT<sup><a href="#ref-64">64</a>–<a href="#ref-66">66</a></sup>. The studies have shown conflicting results between immune response and its correlation with PTLD<sup><a href="#ref-67">67</a>–<a href="#ref-69">69</a></sup>. More studies are warranted to assess how immunological tools could improve the management of risk associated with EBV in transplantation.</p></div><div class=section><a name=d4572e719 class=n-a></a><h3 class=section-title>BK virus</h3><p class="" id=d4572e724>Functional assays have also been developed to detect specific responses against BK virus. BK virus is a polyomavirus frequently reactivating after kidney transplantation, in urine and sometimes in the blood. This reactivation can lead to BK virus nephropathy and compromised kidney function<sup><a href="#ref-70">70</a></sup>. Schachtner <i>et al</i>. monitored BK virus-specific production of IFN-γ in kidney transplant recipients. The authors showed that a BK virus-specific response was detectable before transplant in 69% of patients. A decrease of this response at day +30 after transplantation was associated with increased risk of BK viremia, and the persistence of this specific response was associated with lower risk of reactivation<sup><a href="#ref-71">71</a></sup>. However, the appropriateness of use of the 15 peptides used in this test has been questioned, as it is known to elicit mainly a CD4<sup>+</sup> T-cell response. Leboeuf <i>et al</i>. recently reported an immune monitoring of BK virus-specific immunity using 9mer peptides in an immunodominant epitope<sup><a href="#ref-72">72</a></sup>. They measured the cellular activity at 0, 6, and 12 months after transplant and showed that viremia was associated with an increase of specific 9mer-specific cellular response. A high response was associated with increased clearance of viremia<sup><a href="#ref-72">72</a></sup>. More studies are warranted to define its use in real-life practice for the management of patients with BK viremia.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4572e757>Immunization</h2><div class=section><a name=d4572e760 class=n-a></a><h3 class=section-title>Shingles vaccines</h3><p class="" id=d4572e765>Herpes zoster virus reactivation can affect up to 20% of SOT patients during their lifetime<sup><a href="#ref-73">73</a></sup>. Immunization pre-transplantation relies on varicella vaccine if the VZV serology is negative and shingles vaccine if the patient is seropositive. However, these vaccines are live attenuated vaccines and therefore are contra-indicated after transplant<sup><a href="#ref-74">74</a></sup>. In transplant candidates, owing to the risk of viremia after transplantation, the administration of live vaccine should be avoided if the transplant is urgent.</p><p class="" id=d4572e776>An inactivated vaccine against shingles was recently approved by the FDA after two randomized trials showing clinical efficacy for the prevention of shingles compared with placebo in adults more than 50 years old<sup><a href="#ref-75">75</a></sup> and more than 70 years old<sup><a href="#ref-76">76</a></sup>. Few data exist in immunocompromised patients, and so far there has been only one immunogenicity study in patients who received autologous stem cell transplant<sup><a href="#ref-77">77</a></sup>. It is indeed a promising option for seropositive patients, but more data are required in SOT patients.</p></div><div class=section><a name=d4572e792 class=n-a></a><h3 class=section-title>Influenza vaccine</h3><p class="" id=d4572e797>A yearly immunization against influenza is recommended in SOT patients, as influenza is associated with significant morbidity in those patients<sup><a href="#ref-78">78</a></sup>. The inactivated flu vaccine is recommended, but its immunogenicity is lower in these patients compared with the general population; seroconversion rates range from 15% to 70%. In the last few years, several studies reported different strategies to optimize flu immunization. Kumar <i>et al</i>. studied the effect of an adjuvanted vaccine in kidney transplant recipients and did not find significant difference in seroconversion rates<sup><a href="#ref-79">79</a></sup>. A randomized clinical trial performed on 499 solid organ transplant recipients compared the use of two doses versus one dose of inactivated influenza vaccine. The seroprotection rates were higher in patients who received two doses separated by 5 weeks<sup><a href="#ref-80">80</a></sup>. The inactivated high-dose vaccine, with a fourfold increased quantity of antigens compared with inactivated standard-dose vaccine, has been shown to induce better immunogenicity and clinical efficacy in elderly people<sup><a href="#ref-81">81</a></sup>. Natori <i>et al</i>. recently reported the results of a randomized clinical trial comparing standard- and high-dose inactivated influenza vaccine in 161 SOT patients and showed higher seroconversion rates with high-dose vaccine compared with standard-dose vaccine. Both vaccines (high and standard dose) had similar safety profiles<sup><a href="#ref-82">82</a></sup>.</p></div><div class=section><a name=d4572e828 class=n-a></a><h3 class=section-title>Vaccination for travelers</h3><p class="" id=d4572e833>The increasing number of transplantations done worldwide and the improvement of transplantation outcomes lead to an increasing number of SOT recipients travelling or living in areas endemic for certain infections, raising questions about the opportunity to prevent some of those diseases with vaccination. The decision about vaccines is driven by the epidemiology of infections and the expected exposure of the patient<sup><a href="#ref-83">83</a></sup>. Some vaccines are live attenuated vaccines and subsequently are contra-indicated in SOT recipients (such as yellow fever vaccine and dengue vaccine), whereas others can be administrated to SOT patients (meningococcal vaccine, Japanese encephalitis, rabies, and tick-borne encephalitis). Of note, a recent report of three fatal cases of tick-borne encephalitis in SOT recipients, related to donor-derived infection<sup><a href="#ref-84">84</a></sup>, highlights the potential severity of this viral infection in SOT patients.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4572e849>Conclusions and perspectives</h2><p class="" id=d4572e852>The success of organ transplantation has opened doors to new challenges in infectious diseases, which are compounded by the recognition of new transmissible organisms and multidrug-resistant organisms. However, advances in vaccination may translate into better protection for solid organ transplant recipients. In the very near future, some paradigms in the field of transplant infectious diseases will change, as progress in treating infectious diseases (for instance, hepatitis C) can have a significant impact on organ donation. The emergence of new strategies indicates not only that the development of newer antimicrobials will shape the future of organ transplantation but also that tapping into better diagnostic and prognostic immunological tools can help deliver more personalized care.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d4572e1 class=n-a></a><h2 class=main-title id=d4846>Competing interests</h2><p class=metadata-entry><a name=d4572e110 class=n-a></a><p id=d4572e111> The authors declare that they have no competing interests.</p></p></div><div class=back-section><a name=d4572e1 class=n-a></a><h2 class=main-title id=d4848>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d4572e859 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d5124>References</h2><div class="section ref-list"><a name=d4572e859 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d4572e866 class=n-a></a>Venuta F, Van Raemdonck D: History of lung transplantation. <i>J Thorac Dis.</i> 2017; <b>9</b>(12): 5458–71. <a target=xrefwindow id=d4572e874 href="http://www.ncbi.nlm.nih.gov/pubmed/29312756">PubMed Abstract </a> | <a target=xrefwindow id=d4572e877 href="http://dx.doi.org/10.21037/jtd.2017.11.84">Publisher Full Text </a> | <a target=xrefwindow id=d4572e880 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5757055">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d4572e889 class=n-a></a>Stehlik J, Kobashigawa J, Hunt SA, <i> et al.</i>: Honoring 50 Years of Clinical Heart Transplantation in <i>Circulation</i>: In-Depth State-of-the-Art Review. <i>Circulation.</i> 2018; <b>137</b>(1): 71–87. <a target=xrefwindow id=d4572e903 href="http://www.ncbi.nlm.nih.gov/pubmed/29279339">PubMed Abstract </a> | <a target=xrefwindow id=d4572e907 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.117.029753">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d4572e916 class=n-a></a>Sass DA, Doyle AM: Liver and Kidney Transplantation: A Half-Century Historical Perspective. <i>Med Clin North Am.</i> 2016; <b>100</b>(3): 435–48. <a target=xrefwindow id=d4572e924 href="http://www.ncbi.nlm.nih.gov/pubmed/27095637">PubMed Abstract </a> | <a target=xrefwindow id=d4572e927 href="http://dx.doi.org/10.1016/j.mcna.2015.12.001">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d4572e936 class=n-a></a>Ikejezie J, Shapiro CN, Kim J, <i> et al.</i>: Zika Virus Transmission-Region of the Americas, May 15, 2015-December 15, 2016. <i>Am J Transplant.</i> 2017; <b>17</b>(6): 1681–6. <a target=xrefwindow id=d4572e947 href="http://www.ncbi.nlm.nih.gov/pubmed/28544280">PubMed Abstract </a> | <a target=xrefwindow id=d4572e950 href="http://dx.doi.org/10.1111/ajt.14333">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d4572e959 class=n-a></a>Levi ME: Zika virus: a cause of concern in transplantation? <i>Curr Opin Infect Dis.</i> 2017; <b>30</b>(4): 340–5. <a target=xrefwindow id=d4572e967 href="http://www.ncbi.nlm.nih.gov/pubmed/28632511">PubMed Abstract </a> | <a target=xrefwindow id=d4572e970 href="http://dx.doi.org/10.1097/QCO.0000000000000384">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726740415"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e980 class=n-a></a>Nogueira ML, Estofolete CF, Terzian AC, <i> et al.</i>: Zika Virus Infection and Solid Organ Transplantation: A New Challenge. <i>Am J Transplant.</i> 2017; <b>17</b>(3): 791–5. <a target=xrefwindow id=d4572e991 href="http://www.ncbi.nlm.nih.gov/pubmed/27629942">PubMed Abstract </a> | <a target=xrefwindow id=d4572e994 href="http://dx.doi.org/10.1111/ajt.14047">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726740415">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d4572e1007 class=n-a></a>Schwartzmann PV, Ramalho LN, Neder L, <i> et al.</i>: Zika Virus Meningoencephalitis in an Immunocompromised Patient. <i>Mayo Clin Proc.</i> 2017; <b>92</b>(3): 460–6. <a target=xrefwindow id=d4572e1018 href="http://www.ncbi.nlm.nih.gov/pubmed/28259231">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1021 href="http://dx.doi.org/10.1016/j.mayocp.2016.12.019">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d4572e1030 class=n-a></a>Muñoz LS, Parra B, Pardo CA: Neurological Implications of Zika Virus Infection in Adults. <i>J Infect Dis.</i> 2017; <b>216</b>(suppl_10): S897–S905. <a target=xrefwindow id=d4572e1038 href="http://www.ncbi.nlm.nih.gov/pubmed/29267923">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1041 href="http://dx.doi.org/10.1093/infdis/jix511">Publisher Full Text </a> | <a target=xrefwindow id=d4572e1044 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5853915">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726368071"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e1053 class=n-a></a>Silveira FP, Campos SV: The Zika epidemics and transplantation. <i>J Heart Lung Transplant.</i> 2016; <b>35</b>(5): 560–3. <a target=xrefwindow id=d4572e1061 href="http://www.ncbi.nlm.nih.gov/pubmed/27197772">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1064 href="http://dx.doi.org/10.1016/j.healun.2016.03.010">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726368071">F1000 Recommendation</a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d4572e1077 class=n-a></a>Lichtenstein GR, Kaiser LR, Tuchman M, <i> et al.</i>: Fatal hyperammonemia following orthotopic lung transplantation. <i>Gastroenterology.</i> 1997; <b>112</b>(1): 236–40. <a target=xrefwindow id=d4572e1088 href="http://www.ncbi.nlm.nih.gov/pubmed/8978364">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1091 href="http://dx.doi.org/10.1016/S0016-5085(97)70240-3">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727420148"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e1100 class=n-a></a>Krutsinger D, Pezzulo A, Blevins AE, <i> et al.</i>: Idiopathic hyperammonemia after solid organ transplantation: Primarily a lung problem? A single-center experience and systematic review. <i>Clin Transplant.</i> 2017; <b>31</b>(5): e12957. <a target=xrefwindow id=d4572e1111 href="http://www.ncbi.nlm.nih.gov/pubmed/28295601">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1114 href="http://dx.doi.org/10.1111/ctr.12957">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727420148">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d4572e1128 class=n-a></a>Bharat A, Cunningham SA, Scott Budinger GR, <i> et al.</i>: Disseminated <i>Ureaplasma</i> infection as a cause of fatal hyperammonemia in humans. <i>Sci Transl Med.</i> 2015; <b>7</b>(284): 284re3. <a target=xrefwindow id=d4572e1142 href="http://www.ncbi.nlm.nih.gov/pubmed/25904745">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1146 href="http://dx.doi.org/10.1126/scitranslmed.aaa8419">Publisher Full Text </a> | <a target=xrefwindow id=d4572e1149 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4677674">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727254666"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e1158 class=n-a></a>Fernandez R, Ratliff A, Crabb D, <i> et al.</i>: Ureaplasma Transmitted From Donor Lungs Is Pathogenic After Lung Transplantation. <i>Ann Thorac Surg.</i> 2017; <b>103</b>(2): 670–1. <a target=xrefwindow id=d4572e1169 href="http://www.ncbi.nlm.nih.gov/pubmed/28109354">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1172 href="http://dx.doi.org/10.1016/j.athoracsur.2016.09.026">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727254666">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733232918"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e1185 class=n-a></a>Fernandez R, Chi M, Ison MG, <i> et al.</i>: Sequelae of Donor-derived Mollicutes Transmission in Lung Recipients. <i>Am J Respir Crit Care Med.</i> 2017; <b>195</b>(5): 687–9. <a target=xrefwindow id=d4572e1196 href="http://www.ncbi.nlm.nih.gov/pubmed/27925760">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1199 href="http://dx.doi.org/10.1164/rccm.201607-1377LE">Publisher Full Text </a> | <a target=xrefwindow id=d4572e1203 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5363979">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733232918">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727648243"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e1216 class=n-a></a>Azar MM, Turbett SE, Fishman JA, <i> et al.</i>: Donor-Derived Transmission of <i>Candida auris</i> During Lung Transplantation. <i>Clin Infect Dis.</i> 2017; <b>65</b>(6): 1040–2. <a target=xrefwindow id=d4572e1230 href="http://www.ncbi.nlm.nih.gov/pubmed/28520901">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1234 href="http://dx.doi.org/10.1093/cid/cix460">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727648243">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d4572e1247 class=n-a></a>Tsay S, Kallen A, Jackson BR, <i> et al.</i>: Approach to the Investigation and Management of Patients With <i>Candida auris</i>, an Emerging Multidrug-Resistant Yeast. <i>Clin Infect Dis.</i> 2018; <b>66</b>(2): 306–11. <a target=xrefwindow id=d4572e1261 href="http://www.ncbi.nlm.nih.gov/pubmed/29020224">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1265 href="http://dx.doi.org/10.1093/cid/cix744">Publisher Full Text </a> | <a target=xrefwindow id=d4572e1268 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5798232">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727142249"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e1277 class=n-a></a>Lockhart SR, Etienne KA, Vallabhaneni S, <i> et al.</i>: Simultaneous Emergence of Multidrug-Resistant <i>Candida auris</i> on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses. <i>Clin Infect Dis.</i> 2017; <b>64</b>(2): 134–40. <a target=xrefwindow id=d4572e1291 href="http://www.ncbi.nlm.nih.gov/pubmed/27988485">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1295 href="http://dx.doi.org/10.1093/cid/ciw691">Publisher Full Text </a> | <a target=xrefwindow id=d4572e1298 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5215215">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727142249">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d4572e1312 class=n-a></a>Muller E, Kahn D, Mendelson M: Renal transplantation between HIV-positive donors and recipients. <i>N Engl J Med.</i> 2010; <b>362</b>(24): 2336–7. <a target=xrefwindow id=d4572e1320 href="http://www.ncbi.nlm.nih.gov/pubmed/20554994">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1323 href="http://dx.doi.org/10.1056/NEJMc0900837">Publisher Full Text </a> | <a target=xrefwindow id=d4572e1326 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5094174">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725353055"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e1335 class=n-a></a>Muller E, Barday Z, Mendelson M, <i> et al.</i>: HIV-positive-to-HIV-positive kidney transplantation--results at 3 to 5 years. <i>N Engl J Med.</i> 2015; <b>372</b>(7): 613–20. <a target=xrefwindow id=d4572e1346 href="http://www.ncbi.nlm.nih.gov/pubmed/25671253">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1349 href="http://dx.doi.org/10.1056/NEJMoa1408896">Publisher Full Text </a> | <a target=xrefwindow id=d4572e1353 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5090019">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725353055">F1000 Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732677198"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e1366 class=n-a></a>Doby BL, Tobian AAR, Segev DL, <i> et al.</i>: Moving from the HIV Organ Policy Equity Act to HIV Organ Policy Equity in action: changing practice and challenging stigma. <i>Curr Opin Organ Transplant.</i> 2018; <b>23</b>(2): 271–8. <a target=xrefwindow id=d4572e1377 href="http://www.ncbi.nlm.nih.gov/pubmed/29432254">PubMed Abstract </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732677198">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732398501"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e1390 class=n-a></a>Suda G, Ogawa K, Morikawa K, <i> et al.</i>: Treatment of hepatitis C in special populations. <i>J Gastroenterol.</i> 2018; <b>53</b>(5): 591–605. <a target=xrefwindow id=d4572e1401 href="http://www.ncbi.nlm.nih.gov/pubmed/29299684">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1404 href="http://dx.doi.org/10.1007/s00535-017-1427-x">Publisher Full Text </a> | <a target=xrefwindow id=d4572e1408 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5910474">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732398501">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d4572e1421 class=n-a></a>Levitsky J, Formica RN, Bloom RD, <i> et al.</i>: The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation. <i>Am J Transplant.</i> 2017; <b>17</b>(11): 2790–802. <a target=xrefwindow id=d4572e1432 href="http://www.ncbi.nlm.nih.gov/pubmed/28556422">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1435 href="http://dx.doi.org/10.1111/ajt.14381">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727010578"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e1444 class=n-a></a>Khan B, Singer LG, Lilly LB, <i> et al.</i>: Successful Lung Transplantation From Hepatitis C Positive Donor to Seronegative Recipient. <i>Am J Transplant.</i> 2017; <b>17</b>(4): 1129–31. <a target=xrefwindow id=d4572e1455 href="http://www.ncbi.nlm.nih.gov/pubmed/27873483">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1458 href="http://dx.doi.org/10.1111/ajt.14137">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727010578">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732855327"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e1472 class=n-a></a>Schlendorf KH, Zalawadiya S, Shah AS, <i> et al.</i>: Early outcomes using hepatitis C-positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies. <i>J Heart Lung Transplant.</i> 2018; pii: S1053-2498(18)31294-4. <a target=xrefwindow id=d4572e1480 href="http://www.ncbi.nlm.nih.gov/pubmed/29530322">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1483 href="http://dx.doi.org/10.1016/j.healun.2018.01.1293">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732855327">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732800989"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e1496 class=n-a></a>Durand CM, Bowring MG, Brown DM, <i> et al.</i>: Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial. <i>Ann Intern Med.</i> 2018; <b>168</b>(8): 533–540. <a target=xrefwindow id=d4572e1507 href="http://www.ncbi.nlm.nih.gov/pubmed/29507971">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1510 href="http://dx.doi.org/10.7326/M17-2871">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732800989">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d4572e1523 class=n-a></a>Tacconelli E, Carrara E, Savoldi A, <i> et al.</i>: Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. <i>Lancet Infect Dis.</i> 2018; <b>18</b>(3): 318–27. <a target=xrefwindow id=d4572e1534 href="http://www.ncbi.nlm.nih.gov/pubmed/29276051">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1537 href="http://dx.doi.org/10.1016/S1473-3099(17)30753-3">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d4572e1546 class=n-a></a>van Duin D, van Delden C; AST Infectious Diseases Community of Practice: Multidrug-resistant gram-negative bacteria infections in solid organ transplantation. <i>Am J Transplant.</i> 2013; <b>13 Suppl 4</b>: 31–41. <a target=xrefwindow id=d4572e1554 href="http://www.ncbi.nlm.nih.gov/pubmed/23464996">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1557 href="http://dx.doi.org/10.1111/ajt.12096">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d4572e1566 class=n-a></a>Wagenlehner FM, Umeh O, Steenbergen J, <i> et al.</i>: Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI). <i>Lancet.</i> 2015; <b>385</b>(9981): 1949–56. <a target=xrefwindow id=d4572e1577 href="http://www.ncbi.nlm.nih.gov/pubmed/25931244">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1580 href="http://dx.doi.org/10.1016/S0140-6736(14)62220-0">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d4572e1589 class=n-a></a>Solomkin J, Hershberger E, Miller B, <i> et al.</i>: Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI). <i>Clin Infect Dis.</i> 2015; <b>60</b>(10): 1462–71. <a target=xrefwindow id=d4572e1600 href="http://www.ncbi.nlm.nih.gov/pubmed/25670823">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1603 href="http://dx.doi.org/10.1093/cid/civ097">Publisher Full Text </a> | <a target=xrefwindow id=d4572e1607 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4412191">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727434339"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e1617 class=n-a></a>Haidar G, Philips NJ, Shields RK, <i> et al.</i>: Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Infections: Clinical Effectiveness and Evolution of Resistance. <i>Clin Infect Dis.</i> 2017; <b>65</b>(1): 110–20. <a target=xrefwindow id=d4572e1631 href="http://www.ncbi.nlm.nih.gov/pubmed/29017262">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1635 href="http://dx.doi.org/10.1093/cid/cix182">Publisher Full Text </a> | <a target=xrefwindow id=d4572e1638 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5848332">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727434339">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d4572e1651 class=n-a></a>Jacobs DM, DiTursi S, Ruh C, <i> et al.</i>: Combination treatment with extended-infusion ceftazidime/avibactam for a KPC-3-producing <i>Klebsiella pneumoniae</i> bacteraemia in a kidney and pancreas transplant patient. <i>Int J Antimicrob Agents.</i> 2016; <b>48</b>(2): 225–7. <a target=xrefwindow id=d4572e1665 href="http://www.ncbi.nlm.nih.gov/pubmed/27396948">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1669 href="http://dx.doi.org/10.1016/j.ijantimicag.2016.06.002">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d4572e1678 class=n-a></a>So M, Mamdani MM, Morris AM, <i> et al.</i>: Effect of an antimicrobial stewardship programme on antimicrobial utilization and costs in patients with leukaemia: a retrospective interventional controlled study. <i>Clin Microbiol Infect.</i> 2017; pii: S1198-743X(17)30639-0. <a target=xrefwindow id=d4572e1686 href="http://www.ncbi.nlm.nih.gov/pubmed/29138099">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1689 href="http://dx.doi.org/10.1016/j.cmi.2017.11.009">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d4572e1698 class=n-a></a>Seo SK, Lo K, Abbo LM: Current State of Antimicrobial Stewardship at Solid Organ and Hematopoietic Cell Transplant Centers in the United States. <i>Infect Control Hosp Epidemiol.</i> 2016; <b>37</b>(10): 1195–200. <a target=xrefwindow id=d4572e1706 href="http://www.ncbi.nlm.nih.gov/pubmed/27457099">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1709 href="http://dx.doi.org/10.1017/ice.2016.149">Publisher Full Text </a> | <a target=xrefwindow id=d4572e1712 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5466005">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d4572e1721 class=n-a></a>Dubberke ER, Riddle DJ; AST Infectious Diseases Community of Practice: <i>Clostridium difficile</i> in solid organ transplant recipients. <i>Am J Transplant.</i> 2009; <b>9 Suppl 4</b>: S35–40. <a target=xrefwindow id=d4572e1732 href="http://www.ncbi.nlm.nih.gov/pubmed/20070693">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1735 href="http://dx.doi.org/10.1111/j.1600-6143.2009.02891.x">Publisher Full Text </a> | <a target=xrefwindow id=d4572e1739 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3899697">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d4572e1748 class=n-a></a>Paudel S, Zacharioudakis IM, Zervou FN, <i> et al.</i>: Prevalence of <i>Clostridium difficile</i> infection among solid organ transplant recipients: a meta-analysis of published studies. <i>PLoS One.</i> 2015; <b>10</b>(4): e0124483. <a target=xrefwindow id=d4572e1762 href="http://www.ncbi.nlm.nih.gov/pubmed/25886133">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1766 href="http://dx.doi.org/10.1371/journal.pone.0124483">Publisher Full Text </a> | <a target=xrefwindow id=d4572e1769 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4401454">Free Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732528877"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e1779 class=n-a></a>Cusini A, Béguelin C, Stampf S, <i> et al.</i>: <i>Clostridium difficile</i> infection is associated with graft loss in solid organ transplant recipients. <i>Am J Transplant.</i> 2018. <a target=xrefwindow id=d4572e1790 href="http://www.ncbi.nlm.nih.gov/pubmed/29349869">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1793 href="http://dx.doi.org/10.1111/ajt.14640">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732528877">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717971425"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e1806 class=n-a></a>van Nood E, Vrieze A, Nieuwdorp M, <i> et al.</i>: Duodenal infusion of donor feces for recurrent <i>Clostridium difficile</i>. <i>N Engl J Med.</i> 2013; <b>368</b>(5): 407–15. <a target=xrefwindow id=d4572e1820 href="http://www.ncbi.nlm.nih.gov/pubmed/23323867">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1824 href="http://dx.doi.org/10.1056/NEJMoa1205037">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717971425">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d4572e1837 class=n-a></a>Ehlermann P, Dösch AO, Katus HA: Donor fecal transfer for recurrent <i>Clostridium difficile</i>-associated diarrhea in heart transplantation. <i>J Heart Lung Transplant.</i> 2014; <b>33</b>(5): 551–3. <a target=xrefwindow id=d4572e1848 href="http://www.ncbi.nlm.nih.gov/pubmed/24742697">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1851 href="http://dx.doi.org/10.1016/j.healun.2014.02.002">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d4572e1860 class=n-a></a>Kelly CR, Ihunnah C, Fischer M, <i> et al.</i>: Fecal microbiota transplant for treatment of <i>Clostridium difficile</i> infection in immunocompromised patients. <i>Am J Gastroenterol.</i> 2014; <b>109</b>(7): 1065–71. <a target=xrefwindow id=d4572e1874 href="http://www.ncbi.nlm.nih.gov/pubmed/24890442">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1878 href="http://dx.doi.org/10.1038/ajg.2014.133">Publisher Full Text </a> | <a target=xrefwindow id=d4572e1881 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5537742">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727623703"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e1890 class=n-a></a>Alrabaa S, Jariwala R, Zeitler K, <i> et al.</i>: Fecal microbiota transplantation outcomes in immunocompetent and immunocompromised patients: A single-center experience. <i>Transpl Infect Dis.</i> 2017; <b>19</b>(4): e12726. <a target=xrefwindow id=d4572e1901 href="http://www.ncbi.nlm.nih.gov/pubmed/28513974">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1904 href="http://dx.doi.org/10.1111/tid.12726">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727623703">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727241020"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e1917 class=n-a></a>Wilcox MH, Gerding DN, Poxton IR, <i> et al.</i>: Bezlotoxumab for Prevention of Recurrent <i>Clostridium difficile</i> Infection. <i>N Engl J Med.</i> 2017; <b>376</b>(4): 305–17. <a target=xrefwindow id=d4572e1931 href="http://www.ncbi.nlm.nih.gov/pubmed/28121498">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1935 href="http://dx.doi.org/10.1056/NEJMoa1602615">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727241020">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726024829"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e1949 class=n-a></a>Maertens JA, Raad II, Marr KA, <i> et al.</i>: Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by <i>Aspergillus</i> and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. <i>Lancet.</i> 2016; <b>387</b>(10020): 760–9. <a target=xrefwindow id=d4572e1963 href="http://www.ncbi.nlm.nih.gov/pubmed/26684607">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1967 href="http://dx.doi.org/10.1016/S0140-6736(15)01159-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726024829">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726213681"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e1980 class=n-a></a>Marty FM, Ostrosky-Zeichner L, Cornely OA, <i> et al.</i>: Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. <i>Lancet Infect Dis.</i> 2016; <b>16</b>(7): 828–37. <a target=xrefwindow id=d4572e1991 href="http://www.ncbi.nlm.nih.gov/pubmed/26969258">PubMed Abstract </a> | <a target=xrefwindow id=d4572e1994 href="http://dx.doi.org/10.1016/S1473-3099(16)00071-2">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726213681">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d4572e2007 class=n-a></a>Lanternier F, Poiree S, Elie C, <i> et al.</i>: Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis. <i>J Antimicrob Chemother.</i> 2015; <b>70</b>(11): 3116–23. <a target=xrefwindow id=d4572e2018 href="http://www.ncbi.nlm.nih.gov/pubmed/26316385">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2021 href="http://dx.doi.org/10.1093/jac/dkv236">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727821376"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e2030 class=n-a></a>Groll AH, Townsend R, Desai A, <i> et al.</i>: Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4. <i>Transpl Infect Dis.</i> 2017; <b>19</b>(5): e12751. <a target=xrefwindow id=d4572e2041 href="http://www.ncbi.nlm.nih.gov/pubmed/28722255">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2044 href="http://dx.doi.org/10.1111/tid.12751">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727821376">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733233036"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e2057 class=n-a></a>Rivosecchi RM, Clancy CJ, Shields RK, <i> et al.</i>: Effects of Isavuconazole on the Plasma Concentrations of Tacrolimus among Solid-Organ Transplant Patients. <i>Antimicrob Agents Chemother.</i> 2017; <b>61</b>(9): pii: e00970-17. <a target=xrefwindow id=d4572e2068 href="http://www.ncbi.nlm.nih.gov/pubmed/28674051">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2071 href="http://dx.doi.org/10.1128/AAC.00970-17">Publisher Full Text </a> | <a target=xrefwindow id=d4572e2075 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5571345">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733233036">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717958326"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e2088 class=n-a></a>Winston DJ, Saliba F, Blumberg E, <i> et al.</i>: Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double-blind, multicenter controlled trial. <i>Am J Transplant.</i> 2012; <b>12</b>(11): 3021–30. <a target=xrefwindow id=d4572e2099 href="http://www.ncbi.nlm.nih.gov/pubmed/22947426">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2102 href="http://dx.doi.org/10.1111/j.1600-6143.2012.04231.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717958326">F1000 Recommendation</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d4572e2116 class=n-a></a>Kotton CN, Kumar D, Caliendo AM, <i> et al.</i>: The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation. <i>Transplantation.</i> 2018. <a target=xrefwindow id=d4572e2124 href="http://www.ncbi.nlm.nih.gov/pubmed/29596116">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2127 href="http://dx.doi.org/10.1097/TP.0000000000002191">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d4572e2136 class=n-a></a>Avery RK, Marty FM, Strasfeld L, <i> et al.</i>: Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients. <i>Transpl Infect Dis.</i> 2010; <b>12</b>(6): 489–96. <a target=xrefwindow id=d4572e2147 href="http://www.ncbi.nlm.nih.gov/pubmed/20682012">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2150 href="http://dx.doi.org/10.1111/j.1399-3062.2010.00550.x">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d4572e2159 class=n-a></a>Alain S, Revest M, Veyer D, <i> et al.</i>: Maribavir use in practice for cytomegalovirus infection in French transplantation centers. <i>Transplant Proc.</i> 2013; <b>45</b>(4): 1603–7. <a target=xrefwindow id=d4572e2170 href="http://www.ncbi.nlm.nih.gov/pubmed/23726629">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2173 href="http://dx.doi.org/10.1016/j.transproceed.2013.01.082">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d4572e2182 class=n-a></a>Strasfeld L, Lee I, Tatarowicz W, <i> et al.</i>: Virologic characterization of multidrug-resistant cytomegalovirus infection in 2 transplant recipients treated with maribavir. <i>J Infect Dis.</i> 2010; <b>202</b>(1): 104–8. <a target=xrefwindow id=d4572e2193 href="http://www.ncbi.nlm.nih.gov/pubmed/20504236">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2196 href="http://dx.doi.org/10.1086/653122">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732233830"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e2205 class=n-a></a>Marty FM, Ljungman P, Chemaly RF, <i> et al.</i>: Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation. <i>N Engl J Med.</i> 2017; <b>377</b>(25): 2433–44. <a target=xrefwindow id=d4572e2216 href="http://www.ncbi.nlm.nih.gov/pubmed/29211658">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2219 href="http://dx.doi.org/10.1056/NEJMoa1706640">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732233830">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d4572e2232 class=n-a></a>Kaul DR, Stoelben S, Cober E, <i> et al.</i>: First report of successful treatment of multidrug-resistant cytomegalovirus disease with the novel anti-CMV compound AIC246. <i>Am J Transplant.</i> 2011; <b>11</b>(5): 1079–84. <a target=xrefwindow id=d4572e2243 href="http://www.ncbi.nlm.nih.gov/pubmed/21521474">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2246 href="http://dx.doi.org/10.1111/j.1600-6143.2011.03530.x">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d4572e2256 class=n-a></a>Stoelben S, Arns W, Renders L, <i> et al.</i>: Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study. <i>Transpl Int.</i> 2014; <b>27</b>(1): 77–86. <a target=xrefwindow id=d4572e2267 href="http://www.ncbi.nlm.nih.gov/pubmed/24164420">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2270 href="http://dx.doi.org/10.1111/tri.12225">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d4572e2279 class=n-a></a>Chou S: Rapid <i>In Vitro</i> Evolution of Human Cytomegalovirus UL56 Mutations That Confer Letermovir Resistance. <i>Antimicrob Agents Chemother.</i> 2015; <b>59</b>(10): 6588–93. <a target=xrefwindow id=d4572e2290 href="http://www.ncbi.nlm.nih.gov/pubmed/26259791">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2293 href="http://dx.doi.org/10.1128/AAC.01623-15">Publisher Full Text </a> | <a target=xrefwindow id=d4572e2297 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4576131">Free Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d4572e2306 class=n-a></a>Vial R, Zandotti C, Alain S, <i> et al.</i>: Brincidofovir Use after Foscarnet Crystal Nephropathy in a Kidney Transplant Recipient with Multiresistant Cytomegalovirus Infection. <i>Case Rep Transplant.</i> 2017; <b>2017</b>: 3624146. <a target=xrefwindow id=d4572e2317 href="http://www.ncbi.nlm.nih.gov/pubmed/28348914">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2320 href="http://dx.doi.org/10.1155/2017/3624146">Publisher Full Text </a> | <a target=xrefwindow id=d4572e2324 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5350387">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726995359"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e2333 class=n-a></a>Faure E, Galperine T, Cannesson O, <i> et al.</i>: Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection. <i>Medicine (Baltimore).</i> 2016; <b>95</b>(44): e5226. <a target=xrefwindow id=d4572e2344 href="http://www.ncbi.nlm.nih.gov/pubmed/27858871">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2347 href="http://dx.doi.org/10.1097/MD.0000000000005226">Publisher Full Text </a> | <a target=xrefwindow id=d4572e2351 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5591119">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726995359">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d4572e2364 class=n-a></a>Fernández-Ruiz M, Kumar D, Humar A: Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation. <i>Clin Transl Immunology.</i> 2014; <b>3</b>(2): e12. <a target=xrefwindow id=d4572e2372 href="http://www.ncbi.nlm.nih.gov/pubmed/25505960">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2375 href="http://dx.doi.org/10.1038/cti.2014.3">Publisher Full Text </a> | <a target=xrefwindow id=d4572e2378 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4232060">Free Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d4572e2387 class=n-a></a>Walker S, Fazou C, Crough T, <i> et al.</i>: <i>Ex vivo</i> monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON<sup>®</sup>-CMV. <i>Transpl Infect Dis.</i> 2007; <b>9</b>(2): 165–70. <a target=xrefwindow id=d4572e2405 href="http://www.ncbi.nlm.nih.gov/pubmed/17462006">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2408 href="http://dx.doi.org/10.1111/j.1399-3062.2006.00199.x">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d4572e2418 class=n-a></a>Kumar D, Chernenko S, Moussa G, <i> et al.</i>: Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients. <i>Am J Transplant.</i> 2009; <b>9</b>(5): 1214–22. <a target=xrefwindow id=d4572e2429 href="http://www.ncbi.nlm.nih.gov/pubmed/19422346">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2432 href="http://dx.doi.org/10.1111/j.1600-6143.2009.02618.x">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717997722"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e2441 class=n-a></a>Manuel O, Husain S, Kumar D, <i> et al.</i>: Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study. <i>Clin Infect Dis.</i> 2013; <b>56</b>(6): 817–24. <a target=xrefwindow id=d4572e2452 href="http://www.ncbi.nlm.nih.gov/pubmed/23196955">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2455 href="http://dx.doi.org/10.1093/cid/cis993">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717997722">F1000 Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d4572e2468 class=n-a></a>Lisboa LF, Kumar D, Wilson LE, <i> et al.</i>: Clinical utility of cytomegalovirus cell-mediated immunity in transplant recipients with cytomegalovirus viremia. <i>Transplantation.</i> 2012; <b>93</b>(2): 195–200. <a target=xrefwindow id=d4572e2479 href="http://www.ncbi.nlm.nih.gov/pubmed/22179399">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2482 href="http://dx.doi.org/10.1097/TP.0b013e31823c1cd4">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727611820"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e2491 class=n-a></a>Kumar D, Mian M, Singer L, <i> et al.</i>: An Interventional Study Using Cell-Mediated Immunity to Personalize Therapy for Cytomegalovirus Infection After Transplantation. <i>Am J Transplant.</i> 2017; <b>17</b>(9): 2468–73. <a target=xrefwindow id=d4572e2502 href="http://www.ncbi.nlm.nih.gov/pubmed/28500691">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2505 href="http://dx.doi.org/10.1111/ajt.14347">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727611820">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d4572e2518 class=n-a></a>Sugaya N, Kimura H, Hara S, <i> et al.</i>: Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8<sup>+</sup> T cells in patients with chronic active EBV infection. <i>J Infect Dis.</i> 2004; <b>190</b>(5): 985–8. <a target=xrefwindow id=d4572e2532 href="http://www.ncbi.nlm.nih.gov/pubmed/15295706">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2536 href="http://dx.doi.org/10.1086/423285">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d4572e2545 class=n-a></a>Guppy AE, Rawlings E, Madrigal JA, <i> et al.</i>: A quantitative assay for Epstein-Barr Virus-specific immunity shows interferon-gamma producing CD8+ T cells increase during immunosuppression reduction to treat posttransplant lymphoproliferative disease. <i>Transplantation.</i> 2007; <b>84</b>(11): 1534–9. <a target=xrefwindow id=d4572e2556 href="http://www.ncbi.nlm.nih.gov/pubmed/18091531">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2559 href="http://dx.doi.org/10.1097/01.tp.0000290232.65830.e7">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d4572e2569 class=n-a></a>Yang J, Lemas VM, Flinn IW, <i> et al.</i>: Application of the ELISPOT assay to the characterization of CD8(+) responses to Epstein-Barr virus antigens. <i>Blood.</i> 2000; <b>95</b>(1): 241–8. <a target=xrefwindow id=d4572e2580 href="http://www.ncbi.nlm.nih.gov/pubmed/10607708">PubMed Abstract </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d4572e2589 class=n-a></a>Smets F, Latinne D, Bazin H, <i> et al.</i>: Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. <i>Transplantation.</i> 2002; <b>73</b>(10): 1603–10. <a target=xrefwindow id=d4572e2600 href="http://www.ncbi.nlm.nih.gov/pubmed/12042647">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2603 href="http://dx.doi.org/10.1097/00007890-200205270-00014">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d4572e2612 class=n-a></a>Wilsdorf N, Eiz-Vesper B, Henke-Gendo C, <i> et al.</i>: EBV-specific T-cell immunity in pediatric solid organ graft recipients with posttransplantation lymphoproliferative disease. <i>Transplantation.</i> 2013; <b>95</b>(1): 247–55. <a target=xrefwindow id=d4572e2623 href="http://www.ncbi.nlm.nih.gov/pubmed/23222899">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2626 href="http://dx.doi.org/10.1097/TP.0b013e318279968d">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d4572e2635 class=n-a></a>Rittà M, Costa C, Sinesi F, <i> et al.</i>: Evaluation of Epstein-Barr virus-specific immunologic response in solid organ transplant recipients with an enzyme-linked ImmunoSpot assay. <i>Transplant Proc.</i> 2013; <b>45</b>(7): 2754–7. <a target=xrefwindow id=d4572e2646 href="http://www.ncbi.nlm.nih.gov/pubmed/24034040">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2649 href="http://dx.doi.org/10.1016/j.transproceed.2013.07.033">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d4572e2658 class=n-a></a>Elfadawy N, Flechner SM, Schold JD, <i> et al.</i>: Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation. <i>Clin J Am Soc Nephrol.</i> 2014; <b>9</b>(3): 553–61. <a target=xrefwindow id=d4572e2669 href="http://www.ncbi.nlm.nih.gov/pubmed/24408118">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2672 href="http://dx.doi.org/10.2215/CJN.08420813">Publisher Full Text </a> | <a target=xrefwindow id=d4572e2676 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3944774">Free Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d4572e2685 class=n-a></a>Schachtner T, Stein M, Babel N, <i> et al.</i>: The Loss of BKV-specific Immunity From Pretransplantation to Posttransplantation Identifies Kidney Transplant Recipients at Increased Risk of BKV Replication. <i>Am J Transplant.</i> 2015; <b>15</b>(8): 2159–69. <a target=xrefwindow id=d4572e2696 href="http://www.ncbi.nlm.nih.gov/pubmed/25808077">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2699 href="http://dx.doi.org/10.1111/ajt.13252">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727450192"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e2709 class=n-a></a>Leboeuf C, Wilk S, Achermann R, <i> et al.</i>: BK Polyomavirus-Specific 9mer CD8 T Cell Responses Correlate With Clearance of BK Viremia in Kidney Transplant Recipients: First Report From the Swiss Transplant Cohort Study. <i>Am J Transplant.</i> 2017; <b>17</b>(10): 2591–600. <a target=xrefwindow id=d4572e2720 href="http://www.ncbi.nlm.nih.gov/pubmed/28326672">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2723 href="http://dx.doi.org/10.1111/ajt.14282">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727450192">F1000 Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d4572e2736 class=n-a></a>Pergam SA, Limaye AP; AST Infectious Diseases Community of Practice: Varicella zoster virus in solid organ transplantation. <i>Am J Transplant.</i> 2013; <b>13 Suppl 4</b>: 138–46. <a target=xrefwindow id=d4572e2744 href="http://www.ncbi.nlm.nih.gov/pubmed/23465007">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2747 href="http://dx.doi.org/10.1111/ajt.12107">Publisher Full Text </a> | <a target=xrefwindow id=d4572e2750 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5331930">Free Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d4572e2759 class=n-a></a>Danziger-Isakov L, Kumar D; AST Infectious Diseases Community of Practice: Vaccination in solid organ transplantation. <i>Am J Transplant.</i> 2013; <b>13 Suppl 4</b>: 311–7. <a target=xrefwindow id=d4572e2767 href="http://www.ncbi.nlm.nih.gov/pubmed/23465023">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2770 href="http://dx.doi.org/10.1111/ajt.12122">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725450973"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e2779 class=n-a></a>Lal H, Cunningham AL, Godeaux O, <i> et al.</i>: Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. <i>N Engl J Med.</i> 2015; <b>372</b>(22): 2087–96. <a target=xrefwindow id=d4572e2790 href="http://www.ncbi.nlm.nih.gov/pubmed/25916341">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2793 href="http://dx.doi.org/10.1056/NEJMoa1501184">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725450973">F1000 Recommendation</a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726737718"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e2806 class=n-a></a>Cunningham AL, Lal H, Kovac M, <i> et al.</i>: Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older. <i>N Engl J Med.</i> 2016; <b>375</b>(11): 1019–32. <a target=xrefwindow id=d4572e2817 href="http://www.ncbi.nlm.nih.gov/pubmed/27626517">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2820 href="http://dx.doi.org/10.1056/NEJMoa1603800">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726737718">F1000 Recommendation</a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d4572e2833 class=n-a></a>Stadtmauer EA, Sullivan KM, Marty FM, <i> et al.</i>: A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients. <i>Blood.</i> 2014; <b>124</b>(19): 2921–9. <a target=xrefwindow id=d4572e2844 href="http://www.ncbi.nlm.nih.gov/pubmed/25237196">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2847 href="http://dx.doi.org/10.1182/blood-2014-04-573048">Publisher Full Text </a> | <a target=xrefwindow id=d4572e2851 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4327150">Free Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d4572e2861 class=n-a></a>Kumar D, Ferreira VH, Blumberg E, <i> et al.</i>: A Five-year Prospective Multi-center Evaluation of Influenza Infection in Transplant Recipients. <i>Clin Infect Dis.</i> 2018. <a target=xrefwindow id=d4572e2869 href="http://www.ncbi.nlm.nih.gov/pubmed/29635437">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2872 href="http://dx.doi.org/10.1093/cid/ciy294">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725765475"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e2881 class=n-a></a>Kumar D, Campbell P, Hoschler K, <i> et al.</i>: Randomized Controlled Trial of Adjuvanted Versus Nonadjuvanted Influenza Vaccine in Kidney Transplant Recipients. <i>Transplantation.</i> 2016; <b>100</b>(3): 662–9. <a target=xrefwindow id=d4572e2892 href="http://www.ncbi.nlm.nih.gov/pubmed/26335915">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2895 href="http://dx.doi.org/10.1097/TP.0000000000000861">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725765475">F1000 Recommendation</a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727464244"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e2908 class=n-a></a>Cordero E, Roca-Oporto C, Bulnes-Ramos A, <i> et al.</i>: Two Doses of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant Recipients: Results of TRANSGRIPE 1-2, a Randomized Controlled Clinical Trial. <i>Clin Infect Dis.</i> 2017; <b>64</b>(7): 829–38. <a target=xrefwindow id=d4572e2919 href="http://www.ncbi.nlm.nih.gov/pubmed/28362949">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2922 href="http://dx.doi.org/10.1093/cid/ciw855">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727464244">F1000 Recommendation</a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d4572e2935 class=n-a></a>Falsey AR, Treanor JJ, Tornieporth N, <i> et al.</i>: Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. <i>J Infect Dis.</i> 2009; <b>200</b>(2): 172–80. <a target=xrefwindow id=d4572e2946 href="http://www.ncbi.nlm.nih.gov/pubmed/19508159">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2949 href="http://dx.doi.org/10.1086/599790">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732320399"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e2958 class=n-a></a>Natori Y, Shiotsuka M, Slomovic J, <i> et al.</i>: A Double Blind Randomized Trial of High Dose vs. Standard Dose Influenza Vaccine in Adult Solid Organ Transplant Recipients. <i>Clin Infect Dis.</i> 2017; <b>66</b>(11): 1698–1704. <a target=xrefwindow id=d4572e2969 href="http://www.ncbi.nlm.nih.gov/pubmed/29253089">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2972 href="http://dx.doi.org/10.1093/cid/cix1082">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732320399">F1000 Recommendation</a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d4572e2985 class=n-a></a>Stucchi RSB, Lopes MH, Kumar D, <i> et al.</i>: Vaccine Recommendations for Solid-Organ Transplant Recipients and Donors. <i>Transplantation.</i> 2018; <b>102</b>(2S Suppl 2): S72–S80. <a target=xrefwindow id=d4572e2996 href="http://www.ncbi.nlm.nih.gov/pubmed/29381581">PubMed Abstract </a> | <a target=xrefwindow id=d4572e2999 href="http://dx.doi.org/10.1097/TP.0000000000002012">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727584982"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4572e3009 class=n-a></a>Lipowski D, Popiel M, Perlejewski K, <i> et al.</i>: A Cluster of Fatal Tick-borne Encephalitis Virus Infection in Organ Transplant Setting. <i>J Infect Dis.</i> 2017; <b>215</b>(6): 896–901. <a target=xrefwindow id=d4572e3020 href="http://www.ncbi.nlm.nih.gov/pubmed/28453842">PubMed Abstract </a> | <a target=xrefwindow id=d4572e3023 href="http://dx.doi.org/10.1093/infdis/jix040">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727584982">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 24 May 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-661/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-661/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Division of Infectious Diseases, Multi-Organ Transplant Program, Department of Medicine, University of Toronto, University Health Network, Toronto, ON, Canada<br/> <sup>2</sup> Necker Pasteur Center for Infectious Diseases and Tropical Medicine, Paris Descartes University, IHU Imagine, Paris, France<br/> <p> <div class=margin-bottom> Claire Aguilar <br/> <span>Roles: </span> Writing – Original Draft Preparation </div> <div class=margin-bottom> Shahid Husain <br/> <span>Roles: </span> Writing – Review & Editing </div> <div class=margin-bottom> Olivier Lortholary <br/> <span>Roles: </span> Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-661/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 24 May 2018, 7:661 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.14262.1">https://doi.org/10.12688/f1000research.14262.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2018 Aguilar C <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=15523 data-id=14262 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14262.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-661/v1/pdf?article_uuid=3b91532e-ee39-48cf-87a9-ac76bfc85ab6" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.14262.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Aguilar C, Husain S and Lortholary O. Recent advances in understanding and managing infectious diseases in solid organ transplant recipients [version 1; peer review: 3 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):661 (<a href="https://doi.org/10.12688/f1000research.14262.1" target=_blank>https://doi.org/10.12688/f1000research.14262.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=14262 id=mobile-track-article-signin-14262 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14262?target=/articles/7-661/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=15523 /> <input name=articleId type=hidden value=14262 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Michael Ison</strong>, Divisions of Infectious Diseases & Organ Transplantation, Northwestern University Feinberg School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Oriol Manuel</strong>, Infectious Diseases Service and Transplantation Center, University Hospital (CHUV), University of Lausanne, Switzerland </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Carlos Cervera</strong>, Department of Medicine, Division of Infectious Diseases, University of Alberta, Canada </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 24 May 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-661/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-661/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=8468-34156></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=34627-34154></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=34628-34155></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=3><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-661/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>24 May 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Michael Ison</strong>, Divisions of Infectious Diseases & Organ Transplantation, Northwestern University Feinberg School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Oriol Manuel</strong>, Infectious Diseases Service and Transplantation Center, University Hospital (CHUV), University of Lausanne, Switzerland </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Carlos Cervera</strong>, Department of Medicine, Division of Infectious Diseases, University of Alberta, Canada </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-661/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-661/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in understanding and managing...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-661/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-661/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-661/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Aguilar C et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-661/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-661",
            templates : {
                twitter : "Recent advances in understanding and managing infectious diseases.... Aguilar C et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-661/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in understanding and managing infectious diseases in solid organ transplant recipients", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in understanding and managing infectious diseases in solid organ transplant recipients", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/14262/15523")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "15523");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "34154": 0,
                           "34155": 0,
                           "34156": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "af09eef3-ac2e-43f7-9785-1025f97dead2";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-661.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-661.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-661.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-661.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-661.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>